Has Holly Smith received payments from drug or device companies?

Yes. Drug and device makers reported $342 in general payments to Holly Smith across 18 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Holly Smith did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Holly Smith come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Holly Smith

Psychiatric/Mental Health · Buffalo, NYNPI 1912674292

Payments from drug & device makers

$342in general payments, 2019–2025

Across 18 payments — averaging $19.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alkermes, Inc.$63
Otsuka America Pharmaceutical, Inc.$59
Neurocrine Biosciences, Inc.$57
Indivior Inc.$43
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$40
Sunovion Pharmaceuticals Inc.$26
plus $53 from 3 others

What the payments were for

Food & beverage$342100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alkermes, Inc.	3	$63
Otsuka America Pharmaceutical, Inc.	3	$59
Neurocrine Biosciences, Inc.	3	$57
Indivior Inc.	2	$43
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$40
Sunovion Pharmaceuticals Inc.	2	$26
Lundbeck LLC	1	$21
Teva Pharmaceuticals USA, Inc.	1	$19
AbbVie	1	$13

How this compares

$342 in reported general payments places this provider in the 45th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York →

Medicare billing

Part B allowed, 2024

$1,313

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clozapine	42	$3,705
Duloxetine Hcl	16	$270
Buspirone Hcl	11	$252
Propranolol Hcl	12	$198
Sertraline Hcl	15	$175
Clonazepam	17	$159
Lithium Carbonate	13	$124

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Buffalo

Carl de FrancoBuffalo$28K
Sarah OtwellBuffalo$15K
Tisha TanyiBuffalo$10K
Richard ZawislakBuffalo$10K
Glenn HannDansville$1.3M
Tammy RussoNiskayuna$568K
Carrie EdickSchenectady$484K
Eric SpronzCentereach$448K
Terry Jo Brooks-DevlinTonawanda$176K
Kevin SiewersStaten Island$155K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →